Kedoya Adyaraya Tbk PT (RSGK) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Kedoya Adyaraya Tbk PT stock IDR 576, price IDR 970, that is 40.6% below the price, quality 59 out of 100. Rating: strongly overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range 610.00 IDR – 1,844 IDR · fair‑value band 419.07 IDR – 778.28 IDR · the 970.00 IDR price screens above the 576.27 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Follow Kedoya Adyaraya Tbk PT in your weekly email
Every Wednesday you see whether Kedoya Adyaraya Tbk PT is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. It offers facilities, such as inpatient and outpatient services; and healthcare services, and building and operating hospitals. The company was founded in 1990 and is headquartered in Jakarta, Indonesia.
Show moreShow less
PT Kedoya Adyaraya Tbk is a subsidiary of PT Sarana Meditama Metropolitan Tbk.
Stock analysis
Kedoya Adyaraya Tbk PT (RSGK) currently trades at 970.00 IDR, while our model-based Fair Value estimate is 576.27 IDR, 41% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 864.01 IDR per share, and 3 of the 23 models we run sit above the 970.00 IDR price.
Bear case: the Earnings-Based group reads lowest at 303.62 IDR, and 20 of the 23 models stay below the price. Data coverage for this calculation is low.
Scenario range: 419.07 IDR (bear) to 778.28 IDR (bull), the price of 970.00 IDR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Kedoya Adyaraya Tbk PT reported revenue of 470B IDR in FY2025 versus 435B IDR in FY2021, a compound +1.9%/yr. Reported net income was 34.5B IDR in FY2025, compounding −10.1%/yr from FY2021.
Key figures
Market cap 902B IDR (≈ $50.1M) Micro · P/E ratio 26.4 · P/S ratio 1.76 · EPS (TTM) 36.76 IDR · Net margin 6.7% · Return on equity 4.1% · Return on assets (EBIT) 5.8% (5-year average) · Operating margin 10.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (low confidence).
What moves the price
The share trades about 38% below its 52-week high and 59% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at −41%, RSGK screens richer than that median.
Fair Value models
Bear419.07 IDRFair Value 576.27 IDRBull778.28 IDR
Price 970.00 IDR · Downside -40.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (31.52 IDR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.80/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+6.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.7%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.9%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−19.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−19.0%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 10%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+25.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about +22.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 234 stocks
Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score59 · Above median
Fair Value upside−40.6% · Bottom 25%
Profitability
Return on equity (12 months)4.1% · Below median
Return on assets3.2% · Below median
Net margin (12 months)6.7% · Above median
Operating margin (12 months)10.4% · Above median
Growth and dividend
Revenue growth (quarter YoY)18.9% · Top 25%
Balance sheet
Debt / equity0.12× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (12 months)26.4× · Pricier than median
P/B1.09× · Cheaper than median
P/S (12 months)1.76× · Pricier than median
Price / free cash flow (fiscal year)22.9× · Pricier than median
EV/EBITDA9.6× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 34
FUTURE (revenue growth)95· sector 31
PAST (return on equity)16· sector 32
HEALTH (low debt)94· sector 90
DIVIDEND (yield)0· sector 39
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Kedoya Adyaraya Tbk PT (RSGK) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 576.27 IDR versus a price of 970.00 IDR, about 41% lower (overvalued).
What is the fair value of RSGK?
Our model-based fair value for Kedoya Adyaraya Tbk PT is 576.27 IDR (as of Nov 9, 2026), built from audited fundamentals. The current price: 970.00 IDR.
What is the quality score of RSGK?
Kedoya Adyaraya Tbk PT has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kedoya Adyaraya Tbk PT (RSGK)?
Our model-based price target is the fair value of 576.27 IDR (as of Nov 9, 2026) from 23 valuation models. Cautious scenario 419.07 IDR, optimistic scenario 778.28 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Kedoya Adyaraya Tbk PT stock forecast for 2026?
Our models put fair value at 576.27 IDR, about 41% lower versus a price of 970.00 IDR (overvalued). Cautious scenario 419.07 IDR, optimistic scenario 778.28 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Kedoya Adyaraya Tbk PT (RSGK)?
Kedoya Adyaraya Tbk PT reported trailing-twelve-month revenue of about 512B IDR (latest available figure, as of Nov 9, 2026).
What growth is priced into Kedoya Adyaraya Tbk PT (RSGK)?
For today's price to be fair in a discounted-cash-flow model, Kedoya Adyaraya Tbk PT would have to grow free cash flow by +25.4 % per year for five years (discount rate 15.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.8 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of RSGK use?
Our models discount Kedoya Adyaraya Tbk PT at 15.0 %: a base by market capitalisation (micro), country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kedoya Adyaraya Tbk PT that is +25.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (15.0 %) and the same formula as our fair value.
How much growth has Kedoya Adyaraya Tbk PT (RSGK) delivered so far?
Over the past 5 years revenue at Kedoya Adyaraya Tbk PT grew +9.8 % a year. The price currently implies free-cash-flow growth of +25.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kedoya Adyaraya Tbk PT (RSGK) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Kedoya Adyaraya Tbk PT (+25.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kedoya Adyaraya Tbk PT (RSGK)?
The free-cash-flow yield on the price is 4.37 %: that much free cash flow Kedoya Adyaraya Tbk PT produces per unit of market value. When it exceeds the discount rate of our models (15.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kedoya Adyaraya Tbk PT (RSGK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kedoya Adyaraya Tbk PT it is 576.27 IDR per share (as of Nov 9, 2026), against a price of 970.00 IDR. It is the blended result of 23 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Kedoya Adyaraya Tbk PT stock overvalued or undervalued in 2026?
As of Nov 9, 2026, RSGK trades above its calculated fair value: price 970.00 IDR, fair value 576.27 IDR, a gap of about −41% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RSGK?
No. The price is what the market pays today (970.00 IDR); the fair value is what the company's own numbers justify (576.27 IDR). For Kedoya Adyaraya Tbk PT the two are 393.73 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Kedoya Adyaraya Tbk PT worth?
The market values Kedoya Adyaraya Tbk PT at about 902B IDR (market capitalisation, as of Nov 9, 2026). Per share that is 970.00 IDR; our models calculate a fair value of 576.27 IDR per share.
What do the bullish and bearish scenarios say about RSGK?
Our models span a range for Kedoya Adyaraya Tbk PT: cautious scenario 419.07 IDR, base 576.27 IDR, optimistic 778.28 IDR per share (as of Nov 9, 2026, price 970.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of RSGK?
Kedoya Adyaraya Tbk PT trades at a price-to-earnings ratio of 26.4 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 576.27 IDR is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2021 to 2025), reported earnings: 23.4. Other multiples: P/B 1.1, P/S 1.8, EV/EBITDA 9.6.
How solid is the balance sheet of Kedoya Adyaraya Tbk PT (RSGK)?
Balance-sheet figures for Kedoya Adyaraya Tbk PT (as of Nov 9, 2026): return on equity 4.1%, debt of 0.12 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is RSGK from its 52-week high?
Kedoya Adyaraya Tbk PT trades at 970.00 IDR, about 38% below its 52-week high of 1,560 IDR and 59% above the low of 610.00 IDR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 576.27 IDR is for.
Which stocks are comparable to Kedoya Adyaraya Tbk PT?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kedoya Adyaraya Tbk PT stock attractive at the current price?
The data as of Nov 9, 2026: price 970.00 IDR, calculated fair value 576.27 IDR (−41%), Quality Score 59/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RSGK calculated?
We run Kedoya Adyaraya Tbk PT through 23 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 576.27 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Kedoya Adyaraya Tbk PT itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kedoya Adyaraya Tbk PT (RSGK)?
The closing price on Nov 6, 2026 was 970.00 IDR. Our model-based fair value is 576.27 IDR, about 41% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kedoya Adyaraya Tbk PT right now?
The price sits above even our optimistic bull case (778.28 IDR). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (59/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (419.07 IDR to 778.28 IDR) leaves room in how you read the outcome.
Key figures of Kedoya Adyaraya Tbk PT
How large is the market capitalisation of Kedoya Adyaraya Tbk PT (RSGK)?
The market capitalisation of Kedoya Adyaraya Tbk PT is 902B IDR (≈ $50.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kedoya Adyaraya Tbk PT (RSGK)?
The price-to-sales ratio of Kedoya Adyaraya Tbk PT is 1.76 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kedoya Adyaraya Tbk PT (RSGK)?
Earnings per share at Kedoya Adyaraya Tbk PT are 36.76 IDR (price ÷ EPS = P/E 26.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Kedoya Adyaraya Tbk PT (RSGK)?
The net margin of Kedoya Adyaraya Tbk PT is 6.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kedoya Adyaraya Tbk PT (RSGK)?
The return on equity (ROE) of Kedoya Adyaraya Tbk PT is 4.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kedoya Adyaraya Tbk PT (RSGK)?
On an EBIT basis the return on assets of Kedoya Adyaraya Tbk PT is 5.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kedoya Adyaraya Tbk PT (RSGK)?
The operating margin of Kedoya Adyaraya Tbk PT is 10.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kedoya Adyaraya Tbk PT (RSGK)?
Revenue at Kedoya Adyaraya Tbk PT is growing +18.9% versus a year earlier (3y avg +9.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kedoya Adyaraya Tbk PT (RSGK)?
Earnings per share at Kedoya Adyaraya Tbk PT are growing −13.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Kedoya Adyaraya Tbk PT (RSGK) hold?
Kedoya Adyaraya Tbk PT holds more cash than debt, 40.4B IDR net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Kedoya Adyaraya Tbk PT in the live analysis
One click puts Kedoya Adyaraya Tbk PT on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 9, 2026